SCHEMBL29454276

SCHEMBL29454276

Cc1c(N)cc(F)cc1Cc1ccccc1Cl

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PNMT P11086 1/20 0.40
MPO P05164 1/20 0.40
ADCY10 Q96PN6 1/20 0.39
ALDH1A1 P00352 1/20 0.39
TAAR1 Q96RJ0 2/20 0.39
CNR2 P34972 1/20 0.38
MEN1 O00255 1/20 0.37
GAA P10253 1/20 0.37
KMT2A Q03164 1/20 0.37
IDO1 P14902 3/20 0.37
SLC6A2 P23975 1/20 0.37
SLC6A4 P31645 1/20 0.37
SLC6A3 Q01959 1/20 0.37
AOC3 Q16853 1/20 0.37
PDE3B Q13370 1/20 0.36
PDE3A Q14432 1/20 0.36
P2RX7 Q99572 1/20 0.36
LMNA P02545 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
DAO P14920 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22232679 1.00 PNMT (0.40) PNMTMPOADCY10ALDH1A1TAAR1
SCHEMBL22232480 0.85 SLC6A4 (0.38) ALDH1A1SLC6A2SLC6A4SLC6A3P2RX7
SCHEMBL29454352 0.83 MPO (0.41) MPOADCY10ALDH1A1TAAR1IDO1
SCHEMBL29454303 0.83 PNMT (0.42) PNMTMPOADCY10ALDH1A1TAAR1
SCHEMBL22231703 0.83 MPO (0.41) MPOADCY10ALDH1A1TAAR1IDO1
SCHEMBL22232087 0.83 TAAR1 (0.40) MPOALDH1A1TAAR1CNR2SLC6A2
SCHEMBL22231950 0.83 MPO (0.44) PNMTMPOADCY10ALDH1A1TAAR1
SCHEMBL22232311 0.83 PNMT (0.42) PNMTMPOADCY10ALDH1A1TAAR1
SCHEMBL29454251 0.82 DHFR (0.42) ALDH1A1TAAR1IDO1SLC6A2SLC6A4
SCHEMBL11821187 0.80 PNMT (0.42) PNMTMPOADCY10ALDH1A1TAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12545639-B2 3-substituted phenylamidine compounds, preparation and use thereof PI INDUSTRIES LTD. (IN) 2026-02-10 US disclosed
US-20220089523-A1 3-SUBSTITUTED PHENYLAMIDINE COMPOUNDS, PREPARATION AND USE THEREOF PI INDUSTRIES LTD. (IN) 2022-03-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220089523-A1 3-SUBSTITUTED PHENYLAMIDINE COMPOUNDS, PREPARATION AND USE THEREOF H1-3, PRMT7, PFAS PNMT 103/4885MPO 1451/4885ADCY10 2371/4885
US-12545639-B2 3-substituted phenylamidine compounds, preparation and use thereof CBR1, CBR3, HCCS PNMT 731/4885MPO 2443/4885ADCY10 2564/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.